The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Reflexion Medical
Consulting or Advisory Role - Reflexion Medical
Research Funding - Reflexion Medical (Inst)
Travel, Accommodations, Expenses - Reflexion Medical
A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE).
 
Phuoc T. Tran
Honoraria - Reflexion Medical
Consulting or Advisory Role - Astellas Pharma; Dendreon; GenomeDx; Noxopharm; Reflexion Medical; Reflexion Medical; Regeneron
Research Funding - Astellas Pharma (Inst); Bayer Health (Inst); Reflexion Medical (Inst)
Patents, Royalties, Other Intellectual Property - Compounds and Methods of Use in Ablative Radiotherapy. Patent filed 3/9/2012. PCT/US2012/028475. PCT/WO/2012/122471.
Travel, Accommodations, Expenses - Reflexion Medical
 
Ryan Phillips
No Relationships to Disclose
 
William Shi
No Relationships to Disclose
 
Su Jin Lim
No Relationships to Disclose
 
Emmanuel S. Antonarakis
Honoraria - Astellas Pharma; AstraZeneca; Clovis Oncology; Dendreon; ESSA; Janssen Biotech; Medivation; Merck; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Clovis Oncology; Dendreon; ESSA; Janssen Biotech; Medivation; Merck; Sanofi
Research Funding - Aragon Pharmaceuticals (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Constellation Pharmaceuticals (Inst); Dendreon (Inst); Exelixis (Inst); Genentech (Inst); Janssen Biotech (Inst); Johnson & Johnson (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Sanofi (Inst); Tokai Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Co-inventor of a biomarker technology that has been licensed to Qiagen
Travel, Accommodations, Expenses - Dendreon; Medivation; Sanofi
 
Steven P. Rowe
Stock and Other Ownership Interests - Precision Molecular
Consulting or Advisory Role - Precision Molecular
Research Funding - Precision Molecular
 
Ashley Ross
Stock and Other Ownership Interests - GenomeDx
Honoraria - Bayer; Healthtronics
Consulting or Advisory Role - Blue Earth Diagnostics; Healthtronics
Speakers' Bureau - Blue Earth Diagnostics; Johnson & Johnson; Tempus
Research Funding - metamark genetics
 
Michael A. Gorin
Research Funding - Progenics
 
Curtiland Deville
No Relationships to Disclose
 
Stephen C. Greco
No Relationships to Disclose
 
Channing Judith Paller
Consulting or Advisory Role - Dendreon; Omnitura
Research Funding - Lilly (Inst)
 
Theodore L. DeWeese
No Relationships to Disclose
 
Daniel Y. Song
No Relationships to Disclose
 
Hao Wang
No Relationships to Disclose
 
Michael Anthony Carducci
Consulting or Advisory Role - Abbvie; Astellas Pharma; Foundation Medicine; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); eFFECTOR Therapeutics (Inst); EMD Serono (Inst); Gilead Sciences (Inst); pfizer (Inst)
 
Kenneth J. Pienta
Leadership - CUE Biopharma
Stock and Other Ownership Interests - CUE Biopharma; GreenMark Biomedical; Medsyn Biopharma; Oncopia Therapeutics
Honoraria - Johnson & Johnson; Progenics
Consulting or Advisory Role - Akrevia Therapeutics; Clinomics; CUE Biopharma; GloriousMed Technology
Research Funding - Progenics
Travel, Accommodations, Expenses - CUE Biopharma
 
Martin Pomper
Employment - Johns Hopkins University
Leadership - Cancer Targeting Systems
Stock and Other Ownership Interests - Cancer Targeting Systems
Consulting or Advisory Role - Cancer Targeting Systems
Research Funding - Cancer Targeting Systems; Progenics
Patents, Royalties, Other Intellectual Property - FutureChem USA; Neuraly (Inst); Patents licensed to Cancer Targeting Systems, Progenics Phama and Advanced Accelerator Applications (Inst); Precision Molecular (Inst); Theraly (Inst)
 
Adam P. Dicker
Leadership - American Society for Radiation Oncology; Department of Defense-Prostate Cancer Research Program; NRG Oncology
Stock and Other Ownership Interests - Oncohost
Consulting or Advisory Role - Apex; Celldex; Cybrexa Therapeutics; EMD Serono; Janssen; Johnson & Johnson; Oncohost; Roche; Self Care Catalysts; Third Bridge
Research Funding - Prostate Cancer Foundation
Patents, Royalties, Other Intellectual Property - We recently filed a patient "DOPED BEO COMPOUNDS FOR OPTICALLY STIMULATED LUMINESCENCE (OSL) AND THERMOLUMINESCENCE (TL) RADIATION DOSIMETRY"
Expert Testimony - Wilson Sonsini
Travel, Accommodations, Expenses - EMD Serono; Ferring; Merck KGaA; Self Care Catalysts
Other Relationship - Dreamit Ventures
 
Mario A. Eisenberger
Leadership - Veru
Stock and Other Ownership Interests - Veru; Veru; Veru; Veru
Honoraria - pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Ipsen; pfizer; Sanofi; Sanofi
Research Funding - Genentech; Sanofi; Tokai Pharmaceuticals
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Pfizer; Sanofi; Veru
 
Maximilian Diehn
Stock and Other Ownership Interests - CiberMed
Consulting or Advisory Role - AstraZeneca; BioNTech; Roche
Research Funding - Varian Medical Systems
Patents, Royalties, Other Intellectual Property - Patent filings on ctDNA detection assigned to Stanford University (Inst); Patent filings on tumor treatment resistance mechanisms assigned to Stanford University (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Roche; Varian Medical Systems